Editor's Choice – International Multicentre Study on the Treatment of Infrarenal Penetrating Aortic Ulcers
European Journal of Vascular and Endovascular Surgery · 2026
DOI: 10.1016/j.ejvs.2025.08.063 ↗Kurz gefasst
Multizentrische Studie in der Zeitschrift European Journal of Vascular and Endovascular Surgery, 2026. Verfasst von Daniel Becker und 17 weiteren Autor:innen. Beteiligte Einrichtung: Department of Vascular Surgery, University Hospital, LMU Munich, Munich, Germany; Department of Vascular Surgery, Bern University Hospital, Inselspit…. Hauptthemen laut MEDLINE: Endovascular Procedures, Ulcer, Blood Vessel Prosthesis Implantation, Aortic Diseases. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 24 Literaturangaben.
Abstract (Originalsprache)
OBJECTIVE: This study aimed to evaluate treatment indications, compare therapeutic approaches, and assess outcomes in patients with infrarenal penetrating aortic ulcers (iPAUs). METHODS: This was a retrospective, multicentre, observational study of patients with iPAUs treated between January 2018 and December 2022 across 12 European centres. Treatment strategies included open surgical repair (OSR) and endovascular techniques, including balloon expandable stent grafts (BESGs), covered endovascular reconstruction of the aortic bifurcation (CERAB), and endovascular aortic repair (EVAR) using bifurcated or tube grafts. Primary endpoints were technical success, anatomy dependent graft selection, and safety outcomes. RESULTS: Among 260 patients (mean age 74.2 years, 77.7% men), 96.9% (n = 252) underwent endovascular repair. PAU size was the primary indication in 70.4% of cases. Bifurcated grafts were used in 64.7% (n = 163) and tube grafts in 35.3% (n = 89). Bifurcated grafts were more frequently selected for patients with larger proximal landing zones (21 ± 3 mm vs. 18 ± 5 mm; p < .001), wider aortic bifurcation diameters (20 ± 5 mm vs. 18 ± 4 mm; p < .001), shorter PAU to bifurcation distances (30 ± 24 mm vs. 41 ± 33 mm; p = .003), and larger PAU base diameters (median 22 mm [interquartile range 16, 30] vs. 18 mm [interquartile range 12, 25]; p < .001). Although few patients underwent OSR, the group had high technical success and no 30 day deaths. Technical success rates were 97.8% for BESGs, 100% for CERAB, and 99.3% for EVAR. Median hospital stay was four days. Major adverse events occurred in 3.5%, with a 30 day mortality rate of 1.5% and a re-intervention rate of 8.1%. Chronic obstructive pulmonary disease independently predicted 30 day mortality (odds ratio [OR] 4.063; p = .039) and major adverse events (OR 7.181; p = .035). Over a median follow up of 21.2 months, the overall mortality rate was 19.3% (9.4% aortic related), with a re-intervention rate of 9.9% (9.4% aortic related). CONCLUSION: Endovascular repair, especially with bifurcated grafts, was the preferred safe approach. CERAB and BESGs were effective in anatomically suitable cases.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Vascular Surgery, University Hospital, LMU Munich, Munich, Germany; Department of Vascular Surgery, Bern University Hospital, Inselspital, University of Bern, Bern, Switzerland.
- Department of Vascular Surgery, University Hospital, LMU Munich, Munich, Germany. Electronic address: nikolaos.tsilimparis@med.uni-muenchen.de.
- Department of Vascular Surgery, University Hospital of Verona, Verona, Italy.
- Department of Vascular and Endovascular Surgery, Angiology and Phlebology, University of Medical Sciences, Poznan, Poland.
- Department of Vascular and Endovascular Surgery, Sankt Gertrauden Hospital, Berlin, Germany.
- Department of Vascular and Endovascular Surgery, University Hospital Münster, Münster, Germany.
Zitieren
APA
Becker, D., Tsilimparis, N., Veraldi, G. F., Bruno, S., Kruszyna, L., Passaloglou, I., Oberhuber, A., Ali, A. A., Garabet, W., Schelzig, H., Pratesi, G., Walensi, M., Hoffmann, J. N., Fazzini, S., Dias, N., Kölbel, T., Kotelis, D., & Stana, J. (2026). Editor's Choice – International Multicentre Study on the Treatment of Infrarenal Penetrating Aortic Ulcers. European Journal of Vascular and Endovascular Surgery. https://doi.org/10.1016/j.ejvs.2025.08.063
Vancouver
Becker D, Tsilimparis N, Veraldi GF, Bruno S, Kruszyna L, Passaloglou I, et al. Editor's Choice – International Multicentre Study on the Treatment of Infrarenal Penetrating Aortic Ulcers. European Journal of Vascular and Endovascular Surgery. 2026. doi:10.1016/j.ejvs.2025.08.063
BibTeX
@article{Becker2026,
author = {Becker, Daniel and Tsilimparis, Nikolaos and Veraldi, Gian Franco and Bruno, Salvatore and Kruszyna, Lukasz and Passaloglou, Ioannis and Oberhuber, Alexander and Ali, Ahmed Azhar and Garabet, Wasem and Schelzig, Hubert and Pratesi, Giovanni and Walensi, Mikolaj and Hoffmann, Johannes N and Fazzini, Stefano and Dias, Nuno and Kölbel, Tilo and Kotelis, Drosos and Stana, Jan},
title = {Editor's Choice – International Multicentre Study on the Treatment of Infrarenal Penetrating Aortic Ulcers},
journal = {European Journal of Vascular and Endovascular Surgery},
year = {2026},
doi = {10.1016/j.ejvs.2025.08.063}
}
EUVIMED